A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers

Abitbol, 2010, A canine Arylsulfatase G (ARSG) mutation leading to a sulfatase deficiency is associated with neuronal ceroid lipofuscinosis, Proc. Natl. Acad. Sci. USA, 107, 14775, 10.1073/pnas.0914206107 Alroy, 1992, Adult onset lysosomal storage disease in a Tibetan terrier: clinical, morphological and biochemical studies, Acta Neuropathol., 84, 658, 10.1007/BF00227743 Awano, 2006, A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis, Mol. Genet. Metab., 89, 254, 10.1016/j.ymgme.2006.02.016 Awano, 2006, A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis, Mol. Genet. Metab., 87, 341, 10.1016/j.ymgme.2005.11.005 Axelsen, 1998, Evolution of substrate specificities in the P-type ATPase superfamily, J. Mol. Evol., 46, 84, 10.1007/PL00006286 Behrens, 2010, Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations, Mov. Disord., 25, 1929, 10.1002/mds.22996 Berkovic, 1988, Kufs' disease: a critical reappraisal, Brain, 111, 27, 10.1093/brain/111.1.27 Brüggemann, 2010, Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype, Arch. Neurol., 67, 1357, 10.1001/archneurol.2010.281 Bublitz, 2010, In and out of the cation pumps: P-Type ATPase structure revisited, Curr. Opin. Struct. Biol., 20, 431, 10.1016/j.sbi.2010.06.007 Burneo, 2003, Adult-onset neuronal ceroid lipofuscinosis (Kufs disease) with autosomal dominant inheritance in Alabama, Epilepsia, 44, 841, 10.1046/j.1528-1157.2003.39802.x Crosiers, 2011, Juvenile dystonia–parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation, Parkinsonism Relat. Disord., 17, 135, 10.1016/j.parkreldis.2010.10.011 Di Fonzo, 2007, ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease, Neurology, 68, 1557, 10.1212/01.wnl.0000260963.08711.08 Djarmati, 2009, ATP13A2 variants in early-onset Parkinson's disease patients and controls, Mov. Disord., 24, 2104, 10.1002/mds.22728 Evans, 2005, A variant form of neuronal ceroid lipofuscinosis in American bulldogs, J. Vet. Intern. Med., 19, 44, 10.1111/j.1939-1676.2005.tb02657.x Farias, 2010, An ADAMTS17 splice donor site mutation in dogs with primary lens luxation, Invest. Ophthalmol. Vis. Sci., 51, 4716, 10.1167/iovs.09-5142 Jalanko, 2009, Neuronal ceroid lipofuscinoses, Biochim. Biophys. Acta, 1793, 697, 10.1016/j.bbamcr.2008.11.004 Jolly, 1995, Comparative biology of the neuronal ceroid-lipofuscinoses (NCL): an overview, Am. J. Med. Genet., 57, 307, 10.1002/ajmg.1320570240 Josephson, 2001, Autosomal dominant Kufs' disease: a cause of early onset dementia, J. Neurol. Sci., 188, 51, 10.1016/S0022-510X(01)00546-9 Katz, 2001, Animal models for the ceroid lipofuscinoses, Adv. Genet., 45, 183, 10.1016/S0065-2660(01)45011-5 Katz, 2002, Assessment of plasma carnitine concentrations in relation to ceroid lipofuscinosis in Tibetan terriers, Am. J. Vet. Res., 63, 890, 10.2460/ajvr.2002.63.890 Katz, 2005, A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis, Biochem. Biophys. Res. Commun., 327, 541, 10.1016/j.bbrc.2004.12.038 Katz, 2005, Assessment of retinal function and characterization of lysosomal storage body accumulation in the retinas and brains of Tibetan terriers with ceroid-lipofuscinosis, Am. J. Vet. Res., 66, 67, 10.2460/ajvr.2005.66.67 Katz, 2007, Accumulation of glial fibrillary acidic protein and histone H4 in brain storage bodies of Tibetan terriers with hereditary neuronal ceroid lipofuscinosis, J. Inherit. Metab. Dis., 30, 952, 10.1007/s10545-007-0683-y Lees, 2007, Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation, Neurology, 68, 1553, 10.1212/01.wnl.0000265228.66664.f4 Lin, 2008, Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore, Neurology, 71, 1727, 10.1212/01.wnl.0000335167.72412.68 Melville, 2005, A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs, Genomics, 86, 287, 10.1016/j.ygeno.2005.06.005 Najim al-Din, 1994, Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome, Acta Neurol. Scand., 89, 347, 10.1111/j.1600-0404.1994.tb02645.x Narfstrom, 2007, Neuronal ceroid lipofuscinosis: clinical and morphologic findings in nine affected Polish Owczarek Nizinny (PON) dogs, Vet. Ophthalmol., 10, 111, 10.1111/j.1463-5224.2007.00527.x Nijssen, 2009, Autosomal dominant adult neuronal ceroid lipofuscinosis: parkinsonism due to both striatal and nigral dysfunction, Clin. Neurophysiol., 120, 1782, 10.1016/j.clinph.2009.07.042 Ning, 2008, PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype, Neurology, 70, 1491, 10.1212/01.wnl.0000310427.72236.68 O'Brien, 2005, Genetic mapping of canine multiple system degeneration and ectodermal dysplasia loci, J. Hered., 96, 727, 10.1093/jhered/esi086 Paisán-Ruiz, 2010, Early-onset l-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations, Mov. Disord., 25, 1791, 10.1002/mds.23221 Phillips, 2007, Online resources for SNP analysis: a review and route map, Mol. Biotechnol., 35, 65, 10.1385/MB:35:1:65 Ramirez, 2006, Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase, Nat. Genet., 38, 1184, 10.1038/ng1884 Riis, 1992, Tibetan terrier model of canine ceroid lipofuscinosis, Am. J. Med. Genet., 42, 615, 10.1002/ajmg.1320420437 Sanders, 2010, A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund, Mol. Genet. Metab., 100, 349, 10.1016/j.ymgme.2010.04.009 Santoro, 2011, Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability, Neurogenetics, 12, 33, 10.1007/s10048-010-0259-0 Schmidt, 2009, Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2, Biochem. Biophys. Res. Commun., 383, 198, 10.1016/j.bbrc.2009.03.151 Schneider, 2010, ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation, Mov. Disord., 25, 979, 10.1002/mds.22947 Shibuya, 1998, Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs, J. Neurosci. Res., 52, 268, 10.1002/(SICI)1097-4547(19980501)52:3<268::AID-JNR3>3.0.CO;2-B Siso, 2004, Adult onset thalamocerebellar degeneration in dogs associated to neuronal storage of ceroid lipopigment, Acta Neuropathol., 108, 386, 10.1007/s00401-004-0902-7 Sorensen, 2010, Structural divergence between the two subgroups of P5 ATPases, Biochim. Biophys. Acta, 1797, 846, 10.1016/j.bbabio.2010.04.010 Thever, 2009, Bioinformatic characterization of p-type ATPases encoded within the fully sequenced genomes of 26 eukaryotes, J. Membr. Biol., 229, 115, 10.1007/s00232-009-9176-2 van Diggelen, 2001, Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease, Ann. Neurol., 50, 269, 10.1002/ana.1103 Vilarino-Guell, 2009, ATP13A2 variability in Parkinson disease, Hum. Mutat., 30, 406, 10.1002/humu.20877 Wang, 2009, A new variant of the ATP13A2 gene in Chinese patients with early-onset parkinsonism, Chin. Med. J. (Engl.), 122, 3082 Williams, 2005, Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze pulsy, and dementia, Mov. Disord., 20, 1264, 10.1002/mds.20511 Zini, 2008, Early-onset dementia with prolonged occipital seizures: an atypical case of Kufs disease, Neurology, 71, 1709, 10.1212/01.wnl.0000335164.02634.f6